Description

Atropine β-(n-Morpholinyl)Propionate is a specialized organic compound of significant interest in advanced chemical synthesis and pharmaceutical research. This derivative of atropine, modified with a morpholinylpropionate moiety, is valued for its potential as a key intermediate or precursor in the development of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and fine chemical manufacturers engaged in the development of anticholinergic agents, neurological research compounds, and other sophisticated pharmacologically active molecules. The compound's unique structure makes it a critical building block for targeted molecular modifications.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel anticholinergic and antispasmodic drug candidates.
• Biochemical Research: Used as a reference standard or tool compound in neurological and pharmacological studies targeting muscarinic acetylcholine receptors.
• Fine Chemical Synthesis: Acts as a specialized building block for the preparation of complex molecules with potential therapeutic applications.
• Academic Research: Employed in university and institutional labs for studying structure-activity relationships (SAR) of atropine derivatives.
• Process Development: Utilized in scaling up and optimizing synthetic routes for advanced pharmaceutical manufacturing.

Basic Information

Product Name	Atropine β-(n-Morpholinyl)Propionate
CAS No.	74191-75-6
Molecular Formula	C21H28N2O4
Molecular Weight	372.46 g/mol
Synonyms	Atropine 3-(Morpholin-4-yl)propanoate; Atropine Morpholinylpropionate; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate 3-(morpholin-4-yl)propanoate (ester); Tropine Tropate 3-Morpholinopropionate; Atropine 3-Morpholinopropanoate; Atropine Derivative 74191-75-6
EINECS	Contact for details

Quality Control

Our Atropine β-(n-Morpholinyl)Propionate is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC for assay and purity determination, and is supplied with a corresponding Certificate of Analysis (COA). We adhere to cGMP principles where applicable, ensuring the material meets the stringent requirements for research and development use in pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.